MEDICINAL PREPARATION FOR COMBINED GENE-DIRECTED ENZYME PRODRUG THERAPY AND IMMUNOTHERAPY OF SOLID MALIGNANT TUMOURS (EMBODIMENTS)

ALTERING INFLAMMATORY STATES OF IMMUNE CELLS IN VIVO BY MODULATING CELLULAR ACTIVATION STATES

GENE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES

HYBRID AAV VECTOR ENHANCING TRANSGENE EXPRESSION IN THE LIVER

FIBROBLAST CELL THERAPY FOR TREATMENT OF OSTEOPOROSIS

Compositions and Methods for Treating Disorders Associated with Cone Photoreceptor Cells

GENE THERAPY FOR OCULAR DISEASE

METHODS FOR IMPROVED THERAPEUTIC USE OF RECOMBINANT AAV

METHODS OF TREATING CANCERS

CELLULAR COMPOSITIONS AND METHODS OF TREATMENT I

PROTEIN OR POLYPEPTIDE-LOADED EXTRACELLULAR VESICLE DELIVERY PLATFORM AND APPLICATION THEREOF

REGULATION OF RAN TRANSLATION BY PKR AND EIF2A-P PATHWAYS

METHODS AND SYSTEMS FOR IMPROVED NUCLEIC ACID DELIVERY VIA ULTRASOUND

PROTEIN SCAFFOLDS FOR DISORDERED REGIONS

COMPOSITIONS AND METHODS FOR MODULATING CHOLESTEROL EFFLUX

Use Of P55gamma As Therapeutic Target For Aortic Dissection (ad)

TREATING CHRONIC INFLAMMATION AND CANCER BY MACROPHAGE POLARIZATION

COMPOSITIONS AND METHODS FOR COMPARTMENT-SPECIFIC CARGO DELIVERY

Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof

Hyperactive variants of the transposase protein of the transposon system Sleeping Beauty

SELECTIVE FUNCTIONAL ENHANCEMENT OF STEM CELLS AND OR THEIR GENETIC MATERIAL, WITH GENE TRANSFECTION FOR SHORT-AND LONG-TERM TREATMENT OF AGE-RELATED DISEASE STATES

SECRETED RNA THERAPEUTICS FOR NUCLEAR DELIVERY

IMMUNOMODULATORY COMPOSITIONS AND METHODS

Methods of Administering 3,4-Diaminopyridine

NANOPARTICLE COMPLEXES FOR ENHANCED SAFETY

ALZHEIMER'S DISEASE GENE THERAPEUTICS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE

AAV GENE THERAPY FOR TREATING A NERVOUS SYSTEM DISEASE

METHODS TO TREAT ACUTE KIDNEY INJURY WITH A FLUID

PROTEIN SCAFFOLDS FOR DISORDERED REGIONS

KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF ARTHRITIC DISEASES

CANCER IMMUNOTHERAPIES TO PROMOTE HYPERACUTE REJECTION

Dry Powder Formulations for Messenger RNA

TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF

ALK POLYPEPTIDES AND METHODS OF USE THEREOF

COMPOSITIONS FOR AND METHODS OF TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASE TYPE VI AND TYPE IX

MULTIPARTITE RECEPTOR AND SIGNALING COMPLEXES

COMPOSITIONS AND METHODS FOR FACILITATING DELIVERY OF SYNTHETIC NUCLEIC ACIDS TO CELLS

METHOD FOR EXPRESSING A MUSCLE-SPECIFIC GENE AND CASSETTES FOR SAME

TREATMENT OF MUSCLE FIBROSIS

REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS

REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS

METHODS OF USING LONG NON-CODING RNA-8 (TROLL-8) AS A TARGET FOR CANCER DETECTION AND TREATMENT

VARIANTS OF THE HUMAN ATM PROTEIN FOR THE TREATMENT OF DISEASES RELATED TO AT LEAST ONE MUTATION OF THE ATM GENE

PEG LIPIDOID COMPOUNDS

METHODS OF TREATING DISEASES ASSOCIATED WITH TRAUMATIC BRAIN INJURY

Gene Therapy for NMNAT1-Associated Retinal Degeneration

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

LYOPHILIZED LIPID NANOPARTICLES AND METHODS OF THEIR USE

PROCESS FOR THE PREPARATION OF ERYTHROCYTES LOADED WITH ONE OR MORE SUBSTANCES OF PHARMACEUTICAL INTEREST AND SO OBTAINED ERYTHROCYTES

NAMPT FOR WOUND-HEALING AND STIMULATING HAIR GROWTH AND/OR REGROWTH

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

LIQUID-DISPERSIBLE HALOPYRUVATE FORMULATIONS AND ASSOCIATED METHODS

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

PERMANENT EPIGENETIC GENE SILENCING

CHIMERIC IL-10/CARRIER CONSTRUCTS FOR TREATMENT OF POUCHITIS AND METHODS OF USE

USE OF p55gamma PROTEIN OR ENCODING GENE THEREOF AS TARGET IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING VASCULAR CALCIFICATION

METHODS TO TREAT, PREVENT, OR REDUCE HYPERAMMONEMIA

CGAS SUPER-ENZYMES FOR CANCER IMMUNOTHERAPY

Viral Vectors For Treating Neurogenic Detrusor Overactivity

METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY

LIPID NANOPARTICLES FOR TARGETED DELIVERY OF MRNA

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASES

TARGET SUBSTRATE PROTEIN DEGRADATION PLATFORM

LIPID NANOPARTICLES FOR DELIVERY TO THE EYE OR EAR

A DRUG FOR USE IN THE TREATMENT OF MUSCLE SPASTICITY BY CHEMICAL MUSCLE DENERVATION

METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS

COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY

ENGINEERED PROBIOTICS AND THE APPLICATIONS THEREOF

PREPARATION OF NOVEL TRITERPENE ALCOHOL DERIVATIVES WITH ENHANCED BIOAVAILABILITY FOR CANCER, INFLAMMATION AND PAIN TREATMENT

Lyophilized Pharmaceutical Compositions Comprising A Lipid Nanoparticle

PEPTIDES FOR TREATING PAIN OR REDUCING PAIN SENSITIVITY

COMPOSITION AND METHODS FOR TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

IMMUNE SYSTEM MODULATORS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING INFECTIOUS DISEASES

COMPOSITIONS AND METHODS OF USING TWO-PROMOTER VECTOR FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS

INHIBITOR-RESISTANT MGMT MODIFICATIONS AND MODIFICATION OF MGMT-ENCODING NUCLEIC ACIDS

SINGLE-VECTOR GENE CONSTRUCT COMPRISING INSULIN AND GLUCOKINASE GENES

SMALL EXTRACELLULAR VESICLES EXPRESSING A DOMINANT NEGATIVE AMPK ALPHA 1 MUTANT FOR USE IN THE TREATMENT OF OBESITY

COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY

CIRCULAR RNA VACCINES AND METHODS OF USE THEREOF

DEGRADATION OF TOXINS IN VIVO

COMPOSITIONS AND METHODS OF FAS INHIBITION

COMPOSITION AND METHODS FOR MODULATION OF ELOVL2

THIOESTER CATIONIC LIPIDS

m6A mRNA MODIFICATION IN CANCER TREATMENT

ENGINEERED MICROORGANISM FOR TREATING HYPERPHENYLALANINEMIA AND USE THEREOF

MITAPIVAT THERAPY AND MODULATORS OF CYTOCHROME P450

CHOLINE ACETYLTRANSFERASE AS A THERAPY FOR ENDOTOXEMIA, SEPSIS, COLITIS AND INFLAMMATORY DISEASES

POLYPEPTIDE SEQUENCE OF KDM6B AND APPLICATION OF KDM6B IN REGULATING AND CONTROLLING FUNCTION OF MESENCHYMAL STEM CELL

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH) FIBROSIS

EUKARYOTIC ELONGATION FACTOR-2 KINASE AS A CYTOTOXIC T LYMPHOCYTES BOOSTER

METHODS AND MATERIALS FOR GALGT2 GENE THERAPY

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

METHOD FOR DECREASING DEGENERATION OF RETINAL GANGLION CELLS

METHOD FOR TREATING AND/OR PREVENTING REGNASE-1-RELATED DISEASE

GENE THERAPY FOR GALACTOSEMIA

POLYPEPTIDE BASED ON RECEPTOR-INTERACTING PROTEIN KINASE-3 METHYLATION MODIFICATION AND APPLICATION THEREOF IN CELL NECROPTOSIS-RELATED DISEASES

AAV PARTICLES COMPRISING A LIVER-TROPIC CAPSID PROTEIN AND ALPHA-GALACTOSIDASE AND THEIR USE TO TREAT FABRY DISEASE

USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION

KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle

METHODS FOR THE TEMPORAL REGULATION OF REPROGRAMMING FACTORS IN MAMMALIAN CELLS

CATIONIC POLYMERS

ADENO-ASSOCIATED VECTORS AND VIRIONS TO TREAT GALACTOSEMIA AND METHODS OF USE AND MANUFACTURE

ASH1L degraders and methods of treatment therewith

ADENO-ASSOCIATED VECTORS AND VIRIONS TO TREAT GALACTOSEMIA AND METHODS OF USE AND MANUFACTURE

COMPOSITIONS COMPRISING A LECITHIN CHOLESTEROL ACYLTRANSFERASE VARIANT AND USES THEREOF

GENE THERAPY VECTORS FOR USE IN PARKINSON'S DISEASE

POST-TRANSLATIONAL MODIFICATION CHIMERIC MOLECULE

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

GEL PRECURSOR COMPOSITION, METHOD FOR PRODUCING GEL, AND METHOD FOR ACTIVATING ENZYME

Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell Transfer

Ligand Binding Molecules and Uses Thereof

COMPOSITION FOR IMPROVING, PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE COMPRISING NAMPT-DERIVED PEPTIDE AS ACTIVE INGREDIENT

NEUROPROTECTION GENE THERAPY

GNE AS A THERAPEUTIC AGENT

VARIANTS OF SIRT6 FOR USE IN PREVENTING AND/OR TREATING AGE-RELATED DISEASES

BISPECIFIC ANTIBODIES USING FUNCTIONALIZED POLY-ADP-RIBOSE POLYMERS

ASH1L INHIBITORS AND METHODS OF TREATMENT THEREWITH

NME INHIBITORS AND METHODS OF USING NME INHIBITORS

COMPOUNDS, COMPOSITIONS, METHODS, AND KITS RELATING TO TELOMERE EXTENSION

RECOMBINANT ADENO-ASSOCIATED VIRUSES FOR LESCH-NYHAN DISORDERS AND USES THEREOF

RECOMBINANT AAV VECTORS EXPRESSING OSTEOPROTECTIVE GENES, INCLUDING HAS2 AND LUBRICIN, USEFUL IN THE TREATMENT OF OSTEOARTHRITIS AND RELATED JOINT CONDITIONS IN MAMMALS

COMPOSITIONS AND METHODS FOR ENHANCED PROTEIN PRODUCTION

DESIGNED CONSTITUTIVELY ACTIVE CYCLIC GMP-AMP SYNTHASE AS A GENETICALLY ENCODED STIMULANT OF INTERFERONS

Expression of Bacterial Dinucleotide Cyclases

Treatment Of B27-Negative Uveitis With Inositol Polyphosphate Multikinase (IPMK) Therapeutic Agents Or Indoleamine 2,3-dioxygenase 2 (IDO2) Agonists

TREATMENTS AND METHODS FOR TREATING ALZHEIMER'S DISEASE

Viral Vectors For Treating Neurogenic Detrusor Overactivity

USE OF PERTUSSIS TOXIN AS A THERAPEUTIC AGENT

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

TREATMENT OF EYE DISEASES WITH FRUCTOSYL-AMINO ACID OXIDASE

COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-beta

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

METHODS OF TREATING ADENOCARCINOMA WITH HUMAN MICROBIOTA DERIVED N-ACYL AMIDES

A PHARMACEUTICALLY ACCEPTABLE AQUEOUS GEL COMPOSITION FOR MRNA DELIVERY

BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL

BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS

Application Of PI4KIIIA Protein And Related Membrane Protein Complex In Treating Alzheimer's Disease

CANCER THERAPY

METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS BY SUPPRESION OF TRANSCRIPTION FACTORS

Treatment of Anthrax with Pegylated Capsule-Degrading Enzyme

MUC16 PROMOTER CONTAINING VIRUS

ANTI-INFLAMMATORY PEPTIDES AND COMPOSITION COMPRISING THE SAME

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF

INHIBITORS OF CYTOCHROME P450 FAMILY 7 SUBFAMILY B MEMBER 1 (CYP7B1) FOR USE IN MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS

Viral Vectors For Treating Neurogenic Detrusor Overactivity

GENOME EDITING SYSTEMS COMPRISING REPAIR-MODULATING ENZYME MOLECULES AND METHODS OF THEIR USE

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS

Use of pertussis toxin as a therapeutic agent

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

Cancer Stem Cell Targeted Cancer Vaccines

COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFICIENCY GENE DISRUPTION

NOVEL USE OF MPK38/MELK AS THERAPEUTIC AGENT FOR OBESITY OR METABOLIC DISEASES SPECIFIC TO MIDDLE-AGED MEN

Anti-inflammatory peptides and composition comprising the same

PROBIOTIC SULFATION OF SECONDARY BILE ACIDS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ISCHEMIA AND CARDIOMYOPATHY

TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES

THERAPEUTIC COMBINATIONS INCLUDING INHIBITORS OF THE P2X4 RECEPTOR FOR TREATING AND PREVENTING PROLIFERATIVE DISORDERS

Therapy for Mitochondrial Fatty Acid Beta-Oxidation and Transport Disorders

ACTIVATING MITOTIC CHECKPOINT CONTROL MECHANISMS

METHODS AND COMPOSITIONS

Process of Preparing mRNA-Loaded Lipid Nanoparticles

COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF

LUNG TREATMENT COMPOSITIONS

MITAPIVAT THERAPY AND MODULATORS OF CYTOCHROME P450

COMPOSITIONS COMPRISING SPIRULINA COMPONENTS

A TUNABLE PHOSPHORYLATION-BASED FEEDBACK CONTROLLER OF MAMMALIAN GENE EXPRESSION

Application of RDR protein in tumor therapy

Ocular Compositions and Methods Thereof

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS

Anti-inflammatory peptides and composition comprising the same

TREATMENT OF HYPERBILIRUBINEMIA

ENHANCED HYT-INDUCED PROTEIN DEGRADATION USING LIPID NANOPARTICLE DELIVERY

COMBINATION THERAPY OF MDNA55 AND A VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF-A)

COMPOSITION FOR REGULATING OSTEOCLAST DIFFERENTIATION, AND USE THEREOF

USE OF FRUCTOSYLTRANSFERASE

COMPOSITION CONTAINING FUNCTIONAL BLACK SOYBEAN POWDER BIOCONVERTED BY USING BACILLUS ENZYMES AS ACTIVE INGREDIENT, AND USE THEREOF

Methods for Treating and Monitoring the Status of Cancer

COMPOSITION FOR PREVENTING OR TREATING NEUROMUSCULAR DISEASE, COMPRISING PRMT1 PROTEIN OR GENE ENCODING SAME

ENGINEERED PROBIOTICS FOR EXPRESSION OF FIBER-SYNTHESIZING ENZYMES IN GUT

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

TRANSPOSON, GENE TRANSFER SYSTEM AND METHOD OF USING THE SAME

Permanent Epigenetic Gene Silencing

PEPTIDES FOR TREATMENT AND PREVENTION OF NONALCOHOLIC FATTY LIVER DISEASE AND FIBROSIS

METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS

METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO

AZAINDOLYLPYRIDONE AND DIAZAINDOLYLPYRIDONE COMPOUNDS

Methods of administering 3,4-diaminopridine

METHODS FOR INDUCING CELL DIVISION OF POSTMITOTIC CELLS

PREDICTING CANCER RELAPSE AND TREATMENT OF CANCER DISEASES

ALK POLYPEPTIDES AND METHODS OF USE THEREOF

Methods of administering 3,4-diaminopridine

GENE THERAPEUTICS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

Anti-inflammatory peptides and composition comprising the same

BRK PEPTIDES AND METHODS OF USE

Treatment delivery system and method

DIAGNOSTIC METHODS FOR CANCER USING AXL DECOY RECEPTORS

ACTIVE DELIVERY OF NUCLEIC ACIDS AND PEPTIDES, METHODS AND USES

METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES

Methods and Compositions to Target and Treat Macrophages

Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis

28 KDA GST PROTEINS FROM SCHISTOSOMA FOR THE TREATMENT OF VASCULITIS

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

ENZYME-MEDIATED DEPLETION OF ADENOSINE AND/OR METHYLTHIOADENOSINE

PEG LIPIDOID COMPOUNDS

MICRORNA-MEDIATED METHODS FOR REJUVENATING CNS GLIAL POPULATIONS

NEW USE OF CMTR1 HAVING SIRNA PRODUCTION AND FUNCTION ENHANCING ACTIVITY

METHODS FOR ANALYSIS OF SOMATIC MOBILE ELEMENTS, AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING MYELIN DEFICIENCY BY REJUVENATING GLIAL PROGENITOR CELLS

BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES

COMPOSITIONS AND METHODS FOR TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA AND ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL

COMBINATORIAL THERAPIES INCLUDING IMPLANTABLE DAMPING DEVICES AND BIOLOGIC THERAPEUTIC AGENTS FOR TREATING A CONDITION AND ASSOCIATED SYSTEMS AND METHODS OF USE

MICROBIAL CONSORTIA

USE OF CD83 IN COMBINATION THERAPIES

POLYMER WITH CATIONIC AND HYDROPHOBIC SIDE CHAINS

VIRAL VECTORS FOR TREATING NEUROGENIC DETRUSOR OVERACTIVITY

MICROENCAPSULATION OF NICOTINE FOR TOBACCOLESS ORAL ADMINISTRATION

N6-Methyladenosine Regulators in Uterine Fibroids

POLYNUCLEOTIDES ENCODING PORPHOBILINOGEN DEAMINASE FOR THE TREATMENT OF ACUTE INTERMITTENT PORPHYRIA

Nanoparticle Modification of Human Adipose-Derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases

ADVANCED MICROBIOME THERAPEUTICS ENGINEERED TO PRODUCE SEROTONIN IN VIVO

Methods of treating cancers having a BRCA1 and/or BRCA2 mutation(s)

RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER

Tricine and Citric Acid Lipids

METHODS AND COMPOSITIONS FOR DELIVERY OF AGENTS ACROSS THE BLOOD-BRAIN BARRIER

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE IN TRANSPLANTATION RECIPIENTS

COMPOSITIONS AND METHODS FOR COMPARTMENT-SPECIFIC CARGO DELIVERY

Methods and compositions for genomic integration

SUBCUTANEOUS DELIVERY OF MESSENGER RNA

ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE

The Kinase NEK10 and Its Use in Treating and Diagnosing Bronchiectasis and Other Respiratory Disorders

Compositions targeting the interaction domain between p27KIP1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity

USE OF PHOSPHORYLATED TAU AND P38GAMMA TO TREAT A NEUROLOGICAL CONDITION

Nucleobase Editors

Hydrodynamic Methods for Delivering Fluids to Kidney Tissues and Related Materials and Methods

Peptides and other agents for treating pain and increasing pain sensitivity

Methods and Compositions for Modulationg Heterochromatin Dysfunction, Genomic Instability, and Associate Conditions

Methods of Administering 3,4-Diaminopyridine

INHIBITING THE RNA METHYLTRANSFERASE METTL3 OR ITS INTERACTION WITH EIF3H TO SUPPRESS ONCOGENE TRANSLATION AND TUMORIGENESIS

Hydrogel composition, hydrogel biomedical material, method for facilitating regeneration of bone and manufacturing method of hydrogel composition

REGULATION OF RAN TRANSLATION BY PKR AND EIF2A-P PATHWAYS

NANOCOMPLEXES OF POLYANION-MODIFIED PROTEINS

Histone Deacytlase 6 Modulation of Titin Protein Mediated Cardiac Tissue Stiffness and Method for Same

Dry Powder Formulations for Messenger RNA

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

Methods for Treating Cancer That Has A Phosphatidylinositol 3,4,5-Trisphosphate Rac Exchange Factor 2 (PREX2) Protein Expressed Thereon

PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE

Novel RNA Composition and Production Method for Use in iPS Cell Generation

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF

METHODS OF USING FLT3L-Fc FUSION PROTEINS

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

TREATMENT AND PREVENTION OF OCULAR NEURODEGENERATIVE DISORDER

METHODS FOR IMPROVED THERAPEUTIC USE OF RECOMBINANT AAV

ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS FOR MITIGATING DISEASE-INDUCED TISSUE DAMAGE

COMPOSITIONS AND METHODS FOR DELIVERY OF RNA

REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS

Anti-inflammatory peptides and composition comprising the same

APPLICATION OF TPK AS A TARGET IN ALZHEIMER'S DISEASE

METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS

SYNTHETIC LIPID-LIKE MATERIALS FOR BRAIN DELIVERY

METHODS AND COMPOSITIONS INVOLVING TERT ACTIVATING THERAPIES

COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS

ASH1L inhibitors and methods of treatment therewith

Compositions Comprising Decarboxylated Cannabinoids

METHOD FOR THE MANUFACTURE OF A DOSAGE FORM WITH MUCOADHESIVE PROPERTIES FOR BUCCAL ADMINISTRATION OF BIOLOGICS

METHODS FOR TREATING RAN PROTEIN-ASSOCIATED NEUROLOGICAL DISEASES

NON-VIRAL MODIFICATION OF MESENCHYMAL STEM CELLS

DI-THIOESTER CATIONIC LIPIDS

NOVEL USE OF MPK38/MELK AS THERAPEUTIC AGENT FOR OBESITY OR METABOLIC DISEASES SPECIFIC TO MIDDLE-AGED MEN

FIBROBLAST CELL THERAPY FOR TREATMENT OF OSTEOPOROSIS

METHOD AND VEHICLE FOR DELIVERING AGENTS ACROSS THE BLOOD-BRAIN BARRIER

Pegylated capsule-degrading enzyme for the treatment of anthrax

CAMKK1 AS A NOVEL REGENERATIVE THERAPEUTIC

Pharmaceutical Compositions Comprising Integration-Promoting Peptides

THIOESTER CATIONIC LIPIDS

PRODUCTION AND USE OF EXTRACELLULAR VESICLE-CONTAINED ENAMPT

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

METHODS FOR TREATING NEURODEGENERATIVE DISORDERS

MACROCYCLIC LIPIDS

NME INHIBITORS AND METHODS OF USING NME INHIBITORS

COMBINATION GMCI AND ATRI CANCER TREATMENT

COMPOSITIONS AND METHODS FOR DETOXIFYING BACTERIAL ENDOTOXINS

Method of treating aging-associated cognitive impairment by reducing CCR3

GMCI AND DDRI COMBINATION THERAPY FOR TREATING CANCER

COMPOSITIONS COMPRISING A TWEAK LIGAND AND METHODS OF USING SAME

ONCOLYTIC VIRUS WITH IMPROVED SAFETY AND ANTICANCER EFFECTS

Cleavable lipids

AUTOANTIBODIES AS BIOMARKER OF PARANEOPLASTIC ENCEPHALITIS ASSOCIATED WITH TESTICULAR CANCER

ABHD5 AND PARTIAL HDAC4 FRAGMENTS AND VARIANTS AS A THERAPEUTIC APPROACH FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS AND DOSAGES THEREOF

METHODS OF TREATING IMBALANCE OF PLASMA LIPIDS LEVEL AND FATTY LIVER WITH M2C MACROPHAGES

Gene therapeutics for fibrodysplasia ossificans progressiva

CYSTINE CATIONIC LIPIDS

PIP4Ks SUPPRESS INSULIN SIGNALING AND ENHANCE IMMUNE FUNCTION THROUGH A CATALYTIC-INDEPENDENT MECHANISM

NUCLEIC ACID CONSTRUCT ENCODING Trk FRAGMENT AND USE THEREOF